Eyad G. Farah eyad.farah.wg10@wharton.upenn.edu


Hebrew University, Jerusalem, Israel B.Sc. Pharm., Pharmacy, 1999


Mihir C. Gandhi


mihir.gandhi.wg10@wharton.upenn.edu Duke University, Durham, NC B.A., Chemistry, 2001 B.A., Religion, 2001


David A. Gilboa david.gilboa.wg10@wharton.upenn.edu


University of California — Berkeley, Berkley, CA B.S.E., Bioengineering with Honors, 2003


An opportunity to combine my clinical expertise and business experience to provide strategic leadership for the healthcare industry.


Novartis Pharmaceuticals, East Hanover, NJ


Summer Associate, Marketing Group, Summer 2009


Assisted brand team with the Key Opinion Leaders (KOLs) speaker training and Medical Education. Identified and provided brand team as well as senior management with recommendations on innovative marketing approaches to better reach targeted patient groups. Provided recommendations to senior management on new strategies aimed to promote Novartis Pharmaceutical’s Customer-Centric Initiative.


Super-Pharm, Israel Drug store Manager, 2005-2008 Managed daily operations of a leading drug store branch. Owned a P&L of $6M annual revenues and $1.8M annual expenses budget. Increased profits by 55% in 3 years. Designed comprehensive marketing strategy for the store, including new pricing scheme and advertising campaigns. Hired, trained and led a team of 45 employees from diverse cultural and professional backgrounds.


Pharmacist, 1999-2000; Chief Pharmacist 2000-2004 Oversaw all operations of a $2M annual revenue pharmacy department including budget management, client relations and legal compliance. Promoted community pharmacy programs that strengthened customer loyalty and increased customer count by 5%.


An opportunity to leverage my scientific background and business experience to provide strategic leadership at an innovative healthcare company.


Abbott Molecular Diagnostics Summer Intern, Business Development / Mergers & Acquisitions, Summer 2009 Identified and evaluated potential acquisition targets; delivered recom- mendations to senior management. Developed comprehensive competitive pipeline database to inform company of emerging technology spaces for strategic investment opportunities.


Chapterhouse, LLC.


Associate Consultant, 2006-2008 Constructed best practice pay-for-per- formance methodology; re-aligned client departmental structure for $1B physician-governed health plan to create and release new health plan offering. Developed growth strategy for $50M technology company through market analysis and revenue channel maximization.


Stockamp & Associates Senior Associate, 2003-2006


Managed 12-person implementation team at $1B health system, exceeding all financial and operational targets. Concurrently managed five client Senior Director-level relationships to streamline communications and engender buy-in for operational and process re-design initiatives.


The Advisory Board Company Analyst, 2001-2003


Performed root cause analysis to determine best practices for enhanced margin recovery focused on clinical operational efficiency and throughput best practices. Initiated and cultivated relationships with senior executives.


An entrepreneurial opportunity to build and develop innovative health care ventures.


The TriZetto Group, Newport Beach, CA Special Assistant to the Chairman and CEO, Summer 2009


Advised Board and senior management on enterprise-wide strategic initiatives, new value creation sources and potential acquisitions and partnerships.


Crescendo Bioscience, San Francisco, CA Business Development and Marketing Intern, Summer 2009


Assessed and quantified market opportunity for molecular diagnostic assays to help treat and manage Ankylosing Spondylitis.


Allen & Company LLC, New York, NY Associate, 2006-2008


Performed strategic and M&A advisory and executed equity and debt financings for healthcare, digital media and technology companies. Conducted due diligence and executed principal investments in seed-stage and venture-stage companies.


Genomic Health Inc., Redwood City, CA Market Strategy Associate, 2006 Led development of international growth strategy for Oncotype Dx, a breakthrough breast cancer diagnostic test.


Bain & Company, San Francisco, CA / Stockholm, Sweden


Senior Associate Consultant, 2003-2006 Formulated and implemented business strategies for 7 corporate clients. Conducted strategic due diligence on 15 private equity targets in transactions exceeding $20B.


12


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40